Harbor Investment Advisory’s NeoGenomics NEO Stock Holding History

Harbor Investment Advisory’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,174	Closed	-$34.9K	–	1288
2023 Q2	$34.9K	Buy	2,174 +273	+14%	+$4.5K	﹤0.01%	795
2023 Q1	$33.1K	Buy	1,901 +278	+17%	+$3.96K	﹤0.01%	807
2022 Q4	$15K	Hold	1,623	–	–	﹤0.01%	948
2022 Q3	$14K	Hold	1,623	–	–	﹤0.01%	981
2022 Q2	$13K	Hold	1,623	–	–	﹤0.01%	996
2022 Q1	$20K	Buy	1,623 +493	+44%	+$10.4K	﹤0.01%	932
2021 Q4	$39K	Hold	1,130	–	–	﹤0.01%	806
2021 Q3	$55K	Buy	+1,130	New	+$52.3K	0.01%	721
2020 Q3	–	Sell	-22	Closed	-$1K	–	1209
2020 Q2	$1K	Buy	+22	New	+$610	﹤0.01%	1087

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Harbor Investment Advisory's NEO Position: Q3 2023 in Review

Harbor Investment Advisory sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 2,174 shares — an estimated $34.9K sold.

Harbor Investment Advisory first reported a position in NEO in Q2 2020 and held it in 9 quarters. The position peaked at $55K in Q3 2021. 283 funds tracked by Wall St. Rank hold NEO as of Q3 2023.

Harbor Investment Advisory reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
Harbor Investment Advisory sold 2,174 NeoGenomics shares in Q3 2023, an estimated $34.9K.
Harbor Investment Advisory first reported a position in NeoGenomics in Q2 2020 and held it in 9 quarters.
Harbor Investment Advisory's NeoGenomics position peaked at $55K in Q3 2021.
283 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.

Based on Harbor Investment Advisory's 13F filing for Q3 2023, filed 13 Oct 2023.